ProMIS Neurosciences, Inc.
PMN
$10.57
$0.080.76%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -4.38% | 11.97% | |||
| Gross Profit | 4.38% | -11.97% | |||
| SG&A Expenses | -28.10% | 36.11% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -8.33% | 15.37% | |||
| Operating Income | 8.33% | -15.37% | |||
| Income Before Tax | 7.82% | -14.46% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 7.82% | -14.46% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 7.82% | -14.46% | |||
| EBIT | 8.33% | -15.37% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 30.16% | 18.31% | |||
| Normalized Basic EPS | 30.15% | 18.31% | |||
| EPS Diluted | 30.17% | 17.32% | |||
| Normalized Diluted EPS | 30.15% | 18.31% | |||
| Average Basic Shares Outstanding | 31.97% | 40.13% | |||
| Average Diluted Shares Outstanding | 31.97% | 40.13% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||